MAY 31, 2018 12:00 PM PDT

Cas9-Based Genome Engineering

Presented at: Lab Automation 2018
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor of Pathology & Cell Biology, Columbia University Irving Medical Center
    Biography
      Alejandro (Alex) Chavez, M.D., Ph.D. is an Assistant Professor of Pathology and Cell Biology at Columbia University. His research group strives to push the boundaries of genetic engineering by developing new methods with which to modify and regulate genomes. To date, his lab has generated methods for performing targeted gene activation or repression, developed some of the first synthetic inheritance-biasing elements (gene drives), created techniques for simultaneously generating hundreds of mutant cells, each with a programmed genetic alteration, and constrained evolution through the development of an in vivo mutation prevention system. Dr. Chavez applies these tools either within his own laboratory or in collaboration with others to gain fundamental biological insights with a particular focus towards understanding neurodegenerative diseases and cancer.

    Abstract

    I will discuss three novel technologies that our laboratory has developed in recent years. In the first part of the talk, I will describe our work on engineering variants of the RNA-guided endonuclease, Cas9, for the selective control of gene expression. I will then share our method for endowing Cas9 with single-nucleotide specificity and describe how it can be used to generate an in vivo mutation prevention system. Finally, I will outline a novel technology for the simultaneous generation of hundreds of mutant cells, each with a defined genetic alteration (point mutation, deletion or insertion), as well as methods for tracking the fitness of all generated mutants within a single experiment.
     

    Learning Objectives: 

    1. Current methods for Cas9-based transcriptional activation
    2. Strategy to endow Cas9 with allele specificity
    3. Describe our novel approach to generating and tracking the fitness of hundreds of mutant cell lines within a single experiment


    Show Resources
    You May Also Like
    JAN 23, 2020 9:00 AM PST
    C.E. CREDITS
    JAN 23, 2020 9:00 AM PST
    DATE: January 23, 2020 TIME: 9:00am PST, 12:00pm EST...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    MAY 08, 2020 10:00 AM PDT
    C.E. CREDITS
    MAY 08, 2020 10:00 AM PDT
    DATE: May 8, 2020 TIME: 10:00am PT, 11:00am MT, 1:00pm ET The application of next generation sequencing to interrogate immune repertoires and methods in which these highly complex dataset...
    MAR 03, 2020 9:00 AM PST
    C.E. CREDITS
    MAR 03, 2020 9:00 AM PST
    DATE: March 3, 2020 TIME: 9:00am PT, 12:00pm ET Despite the advances of new drugs and the lowering of carbapenem breakpoints to enhance detection of CRE, there should be no complacency about...
    Loading Comments...
    Show Resources